Although the distinct mechanisms of MALT1 in cancer progression may be quite different from lymphomas, the oncogenic role and therapeutic potential of MALT1 have been well demonstrated in several non-lymphoid solid tumors, including breast cancer, lung cancer, melanoma, and cholangiocarcinoma [24,25,26,27]. The gene discussed is MALT1; the disease is lymphoma.